LINC01094 promotes the invasion of ovarian cancer cells and regulates the Wnt/β‑catenin signaling pathway by targeting miR‑532‑3p Retraction in /10.3892/etm.2024.12545

Chen,Haiyan; Liu,Yanlin; Liu,Ping; Dai,Qiuxiang; Wang,Peiliang

doi:10.3892/etm.2021.10662

LINC01094 promotes the invasion of ovarian cancer cells and regulates the Wnt/β‑catenin signaling pathway by targeting miR‑532‑3p

Retraction in: /10.3892/etm.2024.12545

Authors:
- Haiyan Chen
- Yanlin Liu
- Ping Liu
- Qiuxiang Dai
- Peiliang Wang
View Affiliations

Affiliations: Department of Gynaecology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region 830011, P.R. China, Department of Reproductive Medicine, Hainan West Central Hospital, Danzhou, Hainan 571799, P.R. China, Department of Obstetrical and Gynecology, Hainan Modern Women and Children's Hospital, Haikou, Hainan 570300, P.R. China
Published online on: August 27, 2021 https://doi.org/10.3892/etm.2021.10662
Article Number: 1228
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long non‑coding RNAs (lncRNAs) participate in the development of ovarian cancer (OC). The present study aimed to explore the roles of long intergenic non‑protein coding RNA 1094 (LINC01094) in OC. LINC01094 and microRNA (miR)‑532‑3p expression in OC tissues and cells were measured using reverse transcription‑quantitative PCR. Cell migration and invasion were detected using wound healing assays and Transwell assays, respectively. The binding of LINC01094 or β‑catenin to miR‑126‑5p was detected using a Dual‑luciferase reporter assay, and protein expression was confirmed using western blot analysis. The expression level of LINC01094 in patients with OC was higher in OC tissues compared with in adjacent tissues, and LINC01094 was upregulated in OC cell lines. In addition, LINC01094 overexpression promoted the viability, migration, invasion and cell cycle progression of OC cells, and inhibited OC cell apoptosis. Moreover, LINC01094 negatively regulated miR‑532‑3p in OC cells and tissues. miR‑532‑3p overexpression decreased the viability, migration, invasion and cell cycle progression of OC cells alongside downregulation of Wnt/β‑catenin signaling pathway protein expression, as well as increasing OC cell apoptosis. Inhibition of LINC01094 with small interfering (si)‑LINC01094 and overexpression of LINC01094 respectively reversed the effect of miR‑532‑3p inhibitor and mimics on OC cells. miR‑532‑3p could directly target β‑catenin, and miR‑532‑3p inhibitor increased β‑catenin expression, while si‑LINC01094 attenuated this effect. In addition, LINC01094 overexpression promoted tumor growth in vivo by regulating miR‑532‑3p. Taken together, LINC01094 promoted the growth, migration, invasion and Wnt/β‑catenin signaling pathway expression of OC cells by modulating miR‑532‑3p.

View Figures

View References

1	Eisenhauer EA: Real-world evidence in the treatment of ovarian cancer. Ann Oncol. 28 (Suppl 8):viii61–viii65. 2017.PubMed/NCBI View Article : Google Scholar
2	Leung F, Diamandis EP and Kulasingam V: Ovarian cancer biomarkers: Current state and future implications from high-throughput technologies. Adv Clin Chem. 66:25–77. 2014.PubMed/NCBI
3	Doubeni CA, Doubeni AR and Myers AE: Diagnosis and management of ovarian cancer. Am Fam Physician. 93:937–944. 2016.PubMed/NCBI
4	Liu HD, Xia BR, Jin MZ and Lou G: Organoid of ovarian cancer: Genomic analysis and drug screening. Clin Transl Oncol. 22:1240–1251. 2020.PubMed/NCBI View Article : Google Scholar
5	Kossaï M, Leary A, Scoazec JY and Genestie C: Ovarian cancer: A heterogeneous disease. Pathobiology. 85:41–49. 2018.PubMed/NCBI View Article : Google Scholar
6	Elias KM, Guo J and Bast RC Jr: Early detection of ovarian cancer. Hematol Oncol Clin North Am. 32:903–914. 2018.PubMed/NCBI View Article : Google Scholar
7	Lisio MA, Fu L, Goyeneche A, Gao ZH and Telleria C: High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. 20(952)2019.PubMed/NCBI View Article : Google Scholar
8	Bhan A, Soleimani M and Mandal SS: Long noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981. 2017.PubMed/NCBI View Article : Google Scholar
9	Botti G, Marra L, Malzone MG, Anniciello A, Botti C, Franco R and Cantile M: LncRNA HOTAIR as prognostic circulating marker and potential therapeutic target in patients with tumor diseases. Curr Drug Targets. 18:27–34. 2017.PubMed/NCBI View Article : Google Scholar
10	Fan CN, Ma L and Liu N: Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. J Transl Med. 16(264)2018.PubMed/NCBI View Article : Google Scholar
11	Chao Y and Zhou D: lncRNA-D16366 Is a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma. Med Sci Monit. 25:6581–6586. 2019.PubMed/NCBI View Article : Google Scholar
12	Saeedi N and Ghorbian S: Analysis of clinical important of LncRNA-HOTAIR gene variations and ovarian cancer susceptibility. Mol Biol Rep. 47:7421–7427. 2020.PubMed/NCBI View Article : Google Scholar
13	Yan L, Zhou J, Gao Y, Ghazal S, Lu L, Bellone S, Yang Y, Liu N, Zhao X, Santin AD, et al: Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene. 34:3076–3084. 2015.PubMed/NCBI View Article : Google Scholar
14	Mu Y, Li N and Cui YL: The lncRNA CCAT1 upregulates TGFβR1 via sponging miR-490-3p to promote TGFβ1-induced EMT of ovarian cancer cells. Cancer Cell Int. 18(145)2018.PubMed/NCBI View Article : Google Scholar
15	Gao Y, Meng H, Liu S, Zhang Y, Jiao T, Liu Y, Ou J, Wang D, Yao L, Liu S and Hui N: LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet. 24:841–852. 2015.PubMed/NCBI View Article : Google Scholar
16	Li XX and Yu Q: Linc01094 accelerates the growth and metastatic-related traits of glioblastoma by sponging miR-126-5p. Onco Targets Ther. 13:9917–9928. 2020.PubMed/NCBI View Article : Google Scholar
17	Xu H, Wang X, Wu J, Ji H, Chen Z, Guo H and Hou J: Long non-coding RNA LINC01094 promotes the development of clear cell renal cell carcinoma by upregulating SLC2A3 via MicroRNA-184. Front Genet. 11(562967)2020.PubMed/NCBI View Article : Google Scholar
18	Jiang Y, Li W, Yan Y, Yao X, Gu W and Zhang H: LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis. Cancer Cell Int. 20(274)2020.PubMed/NCBI View Article : Google Scholar
19	Xu J, Zhang P, Sun H and Liu Y: LINC01094/miR-577 axis regulates the progression of ovarian cancer. J Ovarian Res. 13(122)2020.PubMed/NCBI View Article : Google Scholar
20	Mishra S, Yadav T and Rani V: Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 98:12–23. 2016.PubMed/NCBI View Article : Google Scholar
21	Jeffries J, Zhou W, Hsu AY and Deng Q: miRNA-223 at the crossroads of inflammation and cancer. Cancer Lett. 451:136–141. 2019.PubMed/NCBI View Article : Google Scholar
22	Hetta HF, Zahran AM, Shafik EA, El-Mahdy RI, Mohamed NA, Nabil EE, Esmaeel HM, Alkady OA, Elkady A, Mohareb DA, et al: Circulating miRNA-21 and miRNA-23a expression signature as potential biomarkers for early detection of non-small-cell lung cancer. Microrna. 8:206–215. 2019.PubMed/NCBI View Article : Google Scholar
23	Huang H, Huang S, Liang G, Zeng L, Pan J, Yang W, Chen H, Liu J and Pan B: Comparison of kidney-tonifying and blood-activating medicinal herbs vs NSAIDs in patients with knee osteoarthritis: A protocol for a systematic review and meta-analysis. Medicine (Baltimore). 99(e19370)2020.PubMed/NCBI View Article : Google Scholar
24	Zhang L, Tong Z, Sun Z, Zhu G, Shen E and Huang Y: miR-25-3p targets PTEN to regulate the migration, invasion, and apoptosis of esophageal cancer cells via the PI3K/AKT pathway. Biosci Rep. 40(BSR20201901)2020.PubMed/NCBI View Article : Google Scholar
25	Huang L, Tang X, Shi X and Su L: miR-532-5p promotes breast cancer proliferation and migration by targeting RERG. Exp Ther Med. 19:400–408. 2020.PubMed/NCBI View Article : Google Scholar
26	Song X, Wang Z, Jin Y, Wang Y and Duan W: Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC. Am J Transl Res. 7:2254–2261. 2015.PubMed/NCBI
27	Zhou Y, Zheng X, Lu J, Chen W, Li X and Zhao L: Ginsenoside 20(S)-Rg3 inhibits the Warburg effect via modulating DNMT3A/miR-532-3p/HK2 pathway in ovarian cancer cells. Cell Physiol Biochem. 45:2548–2559. 2018.PubMed/NCBI View Article : Google Scholar
28	Chen N and Wang J: Wnt/β-catenin signaling and obesity. Front Physiol. 9(792)2018.PubMed/NCBI View Article : Google Scholar
29	Huang P, Yan R, Zhang X, Wang L, Ke X and Qu Y: Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities. Pharmacol Ther. 196:79–90. 2019.PubMed/NCBI View Article : Google Scholar
30	Gu C, Cai J, Xu Z, Zhou S, Ye L, Yan Q, Zhang Y, Fang Y, Liu Y, Tu C, et al: miR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling. Cell Death Dis. 10(739)2019.PubMed/NCBI View Article : Google Scholar
31	Li X, Zheng P, Ji T, Tang B, Wang Y and Bai S: LINC00052 ameliorates acute kidney injury by sponging miR-532-3p and activating the Wnt signaling pathway. Aging (Albany NY). 13:340–350. 2020.PubMed/NCBI View Article : Google Scholar
32	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
33	Krishnamurthy N and Kurzrock R: Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat Rev. 62:50–60. 2018.PubMed/NCBI View Article : Google Scholar
34	Jia XX, Zhu TT, Huang Y, Zeng XX, Zhang H and Zhang WX: Wnt/β-catenin signaling pathway regulates asthma airway remodeling by influencing the expression of c-Myc and cyclin D1 via the p38 MAPK-dependent pathway. Exp Ther Med. 18:3431–3438. 2019.PubMed/NCBI View Article : Google Scholar
35	Grunewald T and Ledermann JA: Targeted therapies for ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 41:139–152. 2017.PubMed/NCBI View Article : Google Scholar
36	Słomian GJ, Nowak D, Buczkowska M, Głogowska-Gruszka A, Słomian SP, Roczniak W, Janyga S and Nowak P: The role of adiponectin and leptin in the treatment of ovarian cancer patients. Endokrynol Pol. 70:57–63. 2019.PubMed/NCBI View Article : Google Scholar
37	Lambertini M, Horicks F, Del Mastro L, Partridge AH and Demeestere I: Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application. Cancer Treat Rev. 72:65–77. 2019.PubMed/NCBI View Article : Google Scholar
38	Gao P and Wei GH: Genomic Insight into the role of lncRNA in cancer susceptibility. Int J Mol Sci. 18(1239)2017.PubMed/NCBI View Article : Google Scholar
39	Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY, Zhang Y, Li Q and Hua KQ: Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol. 134:121–128. 2014.PubMed/NCBI View Article : Google Scholar
40	Wang P, Liu X, Han G, Dai S, Ni Q, Xiao S and Huang J: Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression. Cell Cycle. 18:2359–2376. 2019.PubMed/NCBI View Article : Google Scholar
41	Booy EP, McRae EK, Koul A, Lin F and McKenna SA: The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation. Mol Cancer. 16(109)2017.PubMed/NCBI View Article : Google Scholar
42	Cai S, Zhang P, Dong S, Li L, Cai J and Xu M: Downregulation of SPINK13 promotes metastasis by regulating uPA in ovarian cancer cells. Cell Physiol Biochem. 45:1061–1071. 2018.PubMed/NCBI View Article : Google Scholar
43	Yu G, Wang W, Deng J and Dong S: LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway. Mol Med Rep. 19:3615–3621. 2019.PubMed/NCBI View Article : Google Scholar
44	Yang Q, Yu Y, Sun Z and Pan Y: Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer. Biomed Pharmacother. 106:61–67. 2018.PubMed/NCBI View Article : Google Scholar
45	Zhu B, Liu W, Liu H, Xu Q and Xu W: LINC01094 down-regulates miR-330-3p and enhances the expression of MSI1 to promote the progression of glioma. Cancer Manag Res. 12:6511–6521. 2020.PubMed/NCBI View Article : Google Scholar
46	Wang QY, Peng L, Chen Y, Liao LD, Chen JX, Li M, Li YY, Qian FC, Zhang YX, Wang F, et al: Characterization of super-enhancer-associated functional lncRNAs acting as ceRNAs in ESCC. Mol Oncol. 14:2203–2230. 2020.PubMed/NCBI View Article : Google Scholar
47	Zhang Y, Xu Y, Feng L, Li F, Sun Z, Wu T, Shi X, Li J and Li X: Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers. Oncotarget. 7:64148–64167. 2016.PubMed/NCBI View Article : Google Scholar
48	Liu Q, Guo X, Que S, Yang X, Fan H, Liu M, Li X and Tang H: LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells. Oncotarget. 8:43768–43781. 2017.PubMed/NCBI View Article : Google Scholar
49	Jiang Y, Zhang H, Li W, Yan Y, Yao X and Gu W: FOXM1-activated LINC01094 promotes clear cell renal cell carcinoma development via microRNA 224-5p/CHSY1. Mol Cell Biol. 40:e00357–19. 2020.PubMed/NCBI View Article : Google Scholar
50	Bian L, Zhi X, Ma L, Zhang J, Chen P, Sun S, Li J, Sun Y and Qin J: Hsa_circRNA_103809 regulated the cell proliferation and migration in colorectal cancer via miR-532-3p/FOXO4 axis. Biochem Biophys Res Commun. 505:346–352. 2018.PubMed/NCBI View Article : Google Scholar
51	Jiang W, Zheng L, Yan Q, Chen L and Wang X: miR-532-3p inhibits metastasis and proliferation of non-small cell lung cancer by targeting FOXP3. J BUON. 24:2287–2293. 2019.PubMed/NCBI
52	Zhang JX, Chen ZH, Chen DL, Tian XP, Wang CY, Zhou ZW, Gao Y, Xu Y, Chen C, Zheng ZS, et al: LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis. Oncogene. 37:2660–2675. 2018.PubMed/NCBI View Article : Google Scholar
53	Huang K, Fan WS, Fu XY, Li YL and Meng YG: Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer. Eur Rev Med Pharmacol Sci. 23:2353–2359. 2019.PubMed/NCBI View Article : Google Scholar
54	Cuesta S, Batuecas J, Severin MJ, Funes A, Rosso SB and Pacchioni AM: Role of Wnt/β-catenin pathway in the nucleus accumbens in long-term cocaine-induced neuroplasticity: A possible novel target for addiction treatment. J Neurochem. 140:114–125. 2017.PubMed/NCBI View Article : Google Scholar
55	Routledge D and Scholpp S: Mechanisms of intercellular Wnt transport. Development. 146(dev176073)2019.PubMed/NCBI View Article : Google Scholar
56	Bełdowski M: Assessment of plasma B-catenin concentration as biomarker of thyroid cancer. Pol Przegl Chir. 87:340–345. 2015.PubMed/NCBI View Article : Google Scholar
57	Zhang C, Zhang Z, Zhang S, Wang W and Hu P: Targeting of Wnt/β-catenin by anthelmintic drug pyrvinium enhances sensitivity of ovarian cancer cells to chemotherapy. Med Sci Monit. 23:266–275. 2017.PubMed/NCBI View Article : Google Scholar
58	Jiang K, Zhi XH, Ma YY and Zhou LQ: Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer. Eur Rev Med Pharmacol Sci. 23:9890–9899. 2019.PubMed/NCBI View Article : Google Scholar
59	Yu B, Ye X, Du Q, Zhu B, Zhai Q and Li XX: The long non-coding RNA CRNDE promotes colorectal carcinoma progression by competitively binding miR-217 with TCF7L2 and enhancing the Wnt/β-catenin signaling pathway. Cell Physiol Biochem. 41:2489–2502. 2017.PubMed/NCBI View Article : Google Scholar
60	da Silva LFI, Da Broi MG, da Luz CM, da Silva LECM, Ferriani RA, Meola J and Navarro PA: miR-532-3p: A possible altered miRNA in cumulus cells of infertile women with advanced endometriosis. Reprod Biomed Online. 42:579–588. 2021.PubMed/NCBI View Article : Google Scholar